Results 51 to 60 of about 1,478 (160)

Medical treatment of fibroids: FIGO best practice guidance

International Journal of Gynecology &Obstetrics, Volume 171, Issue 2, Page 507-512, November 2025.
Abstract Even though uterine fibroids are a widespread condition, the range of approved medical treatment options remains limited. In fact, only a few drugs are officially approved for the therapy of fibroids. In both the USA and the European Medicines Agency region, selected gonadotropin‐releasing hormone (GnRH) antagonists have been approved for this
Ivonne Diaz, Mary Ann Lumsden, Magdalena Zeppernick   +2 more
wiley   +1 more source

Triathletes and Urinary Incontinence: An Investigation of Prevalence and Associated Factors

Neurourology and Urodynamics, Volume 44, Issue 8, Page 1607-1613, November 2025.
ABSTRACT Aims This study aimed to investigate the prevalence of urinary incontinence (UI) among Brazilian female triathletes and to identify associated factors, focusing on demographic, obstetric, and sports‐related variables. Methods A cross‐sectional study was conducted with 90 female triathletes. Data on age, body mass index (BMI), pregnancy history,
Tais Schwamberger, Thuane Huyer da Roza, Eliane Regina Mendoza Arbieto, Isabela Cardoso Ferreira, Letícia Beatrice Tramontin Schuler, Luiz Henrique Cabral Duarte, Soraia Cristina Tonon da Luz   +6 more
wiley   +1 more source

Effectiveness of Erbium: YAG Laser in the Treatment of Vulvovaginal Atrophy in Women Who Survived Breast Cancer

Journal of Cosmetic Dermatology, Volume 24, Issue 9, September 2025.
ABSTRACT Background Genitourinary syndrome of menopause (GSM) is prevalent among breast cancer survivors (BCS), often exacerbated by oncologic treatments and compounded by contraindications to hormone‐based therapies. Vaginal Erbium:YAG laser has emerged as a promising non‐hormonal alternative, though long‐term safety and efficacy data remain scarce ...
Keila Seabra Teles Ferreira, Giovanna Andrade Lopes, Letícia Alves Barbosa, Israel Júnior Borges do Nascimento, Moisés Salgado Pedrosa, George Kroumpouzos, Gisele Viana de Oliveira   +6 more
wiley   +1 more source

我国阴道炎患者阴道分泌物病原体分布情况

Zhongguo shiyan zhenduanxue, 2012
阴道炎（Vaginitis）是指阴道黏膜及黏膜下结缔组织发生炎症,以外阴瘙痒、灼痛、分泌物增多、异味明显等为主要临床表现[1];目前已成为女性生殖器炎症中最常见的一类疾病,估计50%以上的妇女至少发生过一次以上[2]。根据发病原因的不同,可以分为感染性阴道炎（Infectious vaginitis）、刺激性阴道炎（Irritant vaginitis）和萎缩性阴道炎（Atrophic vagini-tis）3种类型,其中感染性阴道炎占到90%以上[3]。
石晓, 王素燕
doaj  

Evaluation of the efficacy of Lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: A pilot randomized controlled trial.

PLoS ONE, 2022
As estrogen level decreases with aging, the vaginal mucosa gets thinner, and collagen amount decreases. In addition, the population of Lactobacillus in the vagina declines, increasing the risk of atrophic vaginitis, bacterial vaginosis, and genitourinary
Remi Yoshikata, Michiko Yamaguchi, Yuri Mase, Ayano Tatsuyuki, Khin Zay Yar Myint, Hiroaki Ohta   +5 more
doaj   +1 more source

Cancer treatment and survivorship statistics, 2025

CA: A Cancer Journal for Clinicians, Volume 75, Issue 4, Page 308-340, July/August 2025.
Abstract The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National ...
Nikita Sandeep Wagle, Leticia Nogueira, Theresa P. Devasia, Angela B. Mariotto, K. Robin Yabroff, Farhad Islami, Ahmedin Jemal, Rick Alteri, Patricia A. Ganz, Rebecca L. Siegel   +9 more
wiley   +1 more source

Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy

International Journal of Women's Health, 2012
Lisa A ChismKarmanos Cancer Institute, Alexander J Walt Comprehensive Breast Center, Detroit, Michigan, USAAbstract: The purpose of this review is to summarize current information regarding the pathophysiology and management of vaginal atrophy (sometimes
Chism LA
doaj  

Menopause hormone therapy: latest developments and clinical practice

Drugs in Context, 2019
Menopause hormone therapy (MHT) is the most efficient treatment for symptoms of acute climacteric syndrome and for efficient prevention of long-term estrogen deficiency. Vaginal administration of low doses of estrogen is a therapy of choice for treatment
Tomas Fait
doaj   +1 more source

Efficacy of Low-Dose (0.3 mg) Conjugated Estrogen Cream for Managing Atrophic Vaginitis

Thai Journal of Obstetrics and Gynaecology, 2013
Objectives:To evaluate efficacy and safety of low-dose conjugated estrogen cream (0.3 mg) for treatment of atrophic vaginitis in postmenopausal women.Methods and Methods: A double-blind, placebo-controlled, randomized trial was conducted during ...
Nungruthai Sinnithithaworn, Lingling Salung, Somsak Pratipannawat   +2 more
doaj  

Female Sexual Dysfunction and Associated Factors Among Married Women in Bahir Dar, Northwest Ethiopia: A Cross‐Sectional Study

Health Science Reports, Volume 8, Issue 6, June 2025.
ABSTRACT Background and Aims Sexual Dysfunction is a hidden factor for countless divorces, which affects 38% of women globally. However, the issue has received less attention and remains under research. Understanding the magnitude and factors associated with Female Sexual Dysfunction is relevant to promoting female sexual and overall health through ...
Heaven Haile, Dabere Nigatu, Zemenu Shiferaw Yadita   +2 more
wiley   +1 more source